Evaluating His-Bundle Pacing for Heart Failure Treatment
Official title: His-Bundle Corrective Pacing in Heart Failure
Run by University of Rochester · NCT05265520 · Data updated 2026-11-12
This study is testing if a new heart pacing method can help people with heart failure and a specific heart block feel better compared to the standard treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 14 sites (Phoenix, Arizona and 13 other locations) |
| Status | Recruiting |
| Started | December 2, 2022 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2028 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT05265520 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with heart failure symptoms and specific ECG criteria indicating the need for cardiac resynchronization therapy.
✕Probably not a fit
Patients with left bundle branch block or those on a heart transplant list are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of His-bundle pacing enhanced cardiac resynchronization therapy (His-CRT) against traditional cardiac resynchronization therapy (BIV-CRT) in patients suffering from heart failure and right bundle branch block (RBBB). The study will assess improvements in left ventricular ejection fraction (LVEF) and various biomarkers over a period of 24 months. Participants will be monitored for changes in their functional status and quality of life, providing insights into the mechanisms of benefit from His-CRT. The trial is designed to be prospective and randomized, involving multiple centers to ensure a diverse patient population.
Why it matters
Potential benefit: If successful, this approach could lead to improved heart function and quality of life for patients with heart failure and RBBB.
How similar studies have gone: While the approach of His-bundle pacing is gaining interest, this specific comparison with BIV-CRT is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older (no upper age limit) * Optimal medical therapy for heart failure by current guidelines * Class IIa or IIb guideline-based indication for CRT-D implant in RBBB patients, including one of the following: * New York Heart Association (NYHA) class II HF symptoms, LVEF ≤ 30% and QRS≥ 150 ms (IIb); OR * NYHA class III-IV a HF, LVEF ≤ 35%, and QRS duration ≥ 150 ms (IIa); OR * NYHA class III-IV a HF, LVEF ≤ 35%, and QRS duration 120-149 ms (IIb) Exclusion Criteria: * Unable to obtain most recent imaging data from echocardiogram within 1 year prior to date of randomization * Left bundle branch block (LBBB) or intraventricular conduction delay (IVCD) ECG morphology * Unable or unwilling to follow study protocol * Less than 12 months life expectancy at consent * Pregnancy or planned pregnancy during duration of the study * On heart transplant list or likely to undergo heart transplant
Where it's running
-
University of Arizona
Phoenix, Arizona, United States Recruiting -
Cedars-Sinai Medical Center
Los Angeles, California, United States Recruiting -
University of South Florida
Tampa, Florida, United States Recruiting -
Northwestern Memorial Hospital
Chicago, Illinois, United States Recruiting -
Rush University Medical Center
Chicago, Illinois, United States Recruiting -
University of Chicago
Chicago, Illinois, United States Recruiting
Show 8 more locations
-
Valley Health System
Ridgewood, New Jersey, United States Recruiting -
Weill Cornell Medical College
New York, New York, United States Recruiting -
Mount Sinai Hospital
New York, New York, United States Recruiting -
Mission Health
Asheville, North Carolina, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
Geisinger Wyoming Valley
Wilkes-Barre, Pennsylvania, United States Recruiting -
University of Vermont
Burlington, Vermont, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Principal investigator: Valentina Kutyifa, MD, PhD — University of Rochester
- Study coordinator: Ann Colasurdo
- Email: ann.colasurdo@heart.rochester.edu
- Phone: 585-275-1054
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing two pacing methods for heart failure patients
This study is testing whether a new pacing method called conduction system pacing can help heart failure patients just as much as the standard biventricular pacing to improve their heart function.
-
Comparing two pacing methods for heart failure treatment
This study is testing which pacing method, conduction system pacing or biventricular pacing, works better for people with heart failure to see if it can help them live longer and avoid hospital visits.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Coronary blood flow testing in people with reduced ejection fraction and left bundle branch block after CRT
This work will test whether direct intracoronary measurements of flow and pressure show reduced coronary blood flow in people with low ejection fraction and left bundle branch block who have a CRT device.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.